Table 1: Distribution of demographic, clinical, and laboratory characteristics among 391 adult HIV-positive study participants.

VariablesFrequencyPercentage or median (IQR)

Age in years39139 (32–46)
Gender
Male09624.55
Female29575.45
Marital status
Single05413.81
Married16441.94
Widow06115.60
Divorce11228.64
Occupation
Formal employment02506.39
Peasant10226.09
Small business12832.74
Driver01203.07
Student00902.30
Housewife04110.49
Others07418.93
BMI categories
Under WT06215.86
Normal WT22557.54
Over WT07017.90
Obese0348.70
WHO stage
3 and 417945.78
1 and 221254.22
Baseline CD4 in cells/µl289 (125–509)
<20012932.99
≥20026267.01
HB in g/dL11 (9.6–12.6)
Anemia
Yes18948.34
No20251.66
Duration on ART (mo)15 (11–21)
IPT use status
No10326.34
Yes28873.66
TB while on ART
Yes04311.00
No34889.00

ART: antiretroviral therapy; HB: hemoglobin; CD4: cluster of differentiation 4; IPT: isoniazid preventive therapy; IQR: interquartile range; mo: months; TB: tuberculosis; WHO: World Health Organization; WT: weight.